Johnson & Johnson Innovative Medicine company-sponsored congress materials which have been accepted for congress presentation at World Conference on Lung Cancer

Enhanced vs standard dermatologic management with amivantamab-lazertinib in EGFRm advanced NSCLC: the COCOON global RCT

CARVYKTI_US-SR-10459

Tremfya Dossier Update- bottom

Lazcluze Dossier Update - bottom

Talvey Digital Dossier banner

CARVYKTI_US-SR-10545

Imaavy Dossier banner

Test-EL

Externally Sponsored Scientific Research

Submit your medical inquiry

Contact J&J Medical Connect for your medical inquiries


This page was last modified on

Additional contact #{index}

janssenscience

Congress Materials

Payer

Dark Blue

oncology

enhanced-vs-standard-dermatologic-video

Whitelist Modal

Enhanced vs standard dermatologic management with amivantamab-lazertinib in EGFRm advanced NSCLC: the COCOON global RCT

Connect with us

Connect with us

Live video

Waiting for agent...

Ready to join